Document Information

7e8b4cc4-1f56-43c3-8ff1-66c35edc6394

Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Van

press_release

Executives Communication Type CEO Company

None

2026-04-20

N/A

1202

18767

Actions
Query with AI Auto Tags
Document Content
# Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations

**Date:** 2026-04-20 09:15:00
**Company:** GSK plc
**Ticker:** GSK
**Source URL:** https://www.globenewswire.com/news-release/2026/04/20/3277121/0/en/Anaptys-Completes-Separation-of-First-Tracks-Biotherapeutics-and-Now-Exclusively-Manages-GSK-and-Vanda-Financial-Collaborations.html

---

[Accessibility: Skip TopNav](https://www.globenewswire.com/news-release/2026/04/20/3277121/0/en/Anaptys-Completes-Separation-of-First-Tracks-Biotherapeutics-and-Now-Exclusively-Manages-GSK-and-Vanda-Financial-Collaborations.html#maincontainer)

[![GlobeNewswire](https://www.globenewswire.com/Home/assests/images/eq-notified-dark.svg)](https://www.globenewswire.com/)

- [Newsroom](https://www.globenewswire.com/newsroom)
- [Services](https://www.globenewswire.com/services)
- [Contact Us](https://insight.notified.com/globenewswire-contact-us?utm_medium=Website&utm_source=Contac...
Showing first 1000 characters. Click "Toggle View" to see full content.